1,577 results on '"Cantón, Rafael"'
Search Results
102. Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)
103. The Impact of Colistin Resistance on the Activation of Innate Immunity by Lipopolysaccharide Modification
104. Status of Herpes Zoster and Herpes Zoster Vaccines in 2023: A position paper
105. Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic
106. Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors
107. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
108. CHROMagar mSuperCARBA performance in carbapenem-resistant Enterobacteriaceae isolates characterized at molecular level and routine surveillance rectal swab specimens
109. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study
110. Characterization and rapid control of a vancomycin-resistant Enterococcus faecium (VREF) outbreak in a renal transplant unit in Spain: The environment matters
111. Puntos de corte de dalbavancina y recomendaciones para el estudio de su actividad in vitro
112. Draft genome sequence of the strain 16-537536, isolated from a patient with bronchiectasis and its relationship to the Pseudomonas koreensis group of the Pseudomonas fluorescens complex
113. Nontuberculous Mycobacteria in Patients with Cystic Fibrosis
114. Stratified reconstruction of ancestral Escherichia coli diversification
115. Outbreak of a Multiresistant Klebsiella pneumoniae Strain in an Intensive Care Unit: Antibiotic Use as Risk Factor for Colonization and Infection
116. A Local Projection Stabilized Lagrange-Galerkin Method for Convection-Diffusion Equations
117. Organization of Patient Management and Fungal Epidemiology in Cystic Fibrosis
118. A Smartphone-Based Platform Assisted by Artificial Intelligence for Reading and Reporting Rapid Diagnostic Tests: Evaluation Study in SARS-CoV-2 Lateral Flow Immunoassays
119. Specific high-resolution scheme to improve understanding of the spatio-temporal dispersion of lymphogranuloma venereum epidemic
120. Antimicrobial resistance in Gram-negative bacilli in Spain: an experts’ view
121. Insights for COVID-19 in 2023
122. The Impact of Colistin Resistance on the Activation of Innate Immunity by Lipopolysaccharide Modification
123. Cefiderocol resistance genomics in sequential chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients
124. Estudios de coste-efectividad con MALDI-TOF e impacto clínico
125. Bronchopulmonary infection–colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study
126. In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies)
127. In vitro activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa and Enterobacteriaceae recovered in Spanish medical centres: Results of the CENIT study
128. Whole-genome sequencing reveals nosocomial Clostridioides difficile transmission and a previously unsuspected epidemic scenario
129. Outbreak by KPC-62-producing ST307 Klebsiella pneumoniae isolates resistant to ceftazidime/avibactam and cefiderocol in a university hospital in Madrid, Spain.
130. Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients
131. Consenso español para la prevención y el tratamiento de la infección bronquial por Pseudomonas aeruginosa en el paciente con fibrosis quística
132. Impact of Automated Blood Culture Systems on the Management of Bloodstream Infections: Results from a Crossover Diagnostic Clinical Trial
133. Reverse Transcription-Loop-Mediated Isothermal Amplification-CRISPR-Cas13a Technology as a Promising Diagnostic Tool for SARS-CoV-2
134. Imipenem-Relebactam Susceptibility in Enterobacterales Isolates Recovered from ICU Patients from Spain and Portugal (SUPERIOR and STEP Studies)
135. Antibacterial spectrum of cefiderocol
136. Isothermal microcalorimetry vs checkerboard assay to evaluate in-vitro synergism of meropenem–amikacin and meropenem–colistin combinations against multi-drug-resistant Gram-negative pathogens
137. «Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents»
138. Time kill-assays of antibiotic combinations for multidrug resistant clinical isolates of OXA-48 carbapenemase producing Klebsiella pneumoniae
139. Relevance of the Consensus Principles for Appropriate Antibiotic Prescribing in 2022
140. «Application of RT-LAMP-CRISPR-Cas13a technology to the detection of OXA-48 producing Klebsiella pneumoniae»
141. Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults
142. Whole-genome analysis of Haemophilus influenzae strains isolated from persons with cystic fibrosis
143. Rapid Detection of Plasmid AmpC Beta-Lactamases by a Flow Cytometry Assay
144. Hidden dissemination of carbapenem-susceptible OXA-48-producing Proteus mirabilis
145. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: A double blind prospective study
146. Breakpoints for carbapenemase-producing Enterobacteriaceae: Is the problem solved?
147. Etest® versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: results from PREMIUM, a European multicentre study
148. CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3
149. A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-negative bacteria
150. Monkeypox in humans: a new outbreak
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.